However, further multi-center clinical studies are needed to validate the use of serum PTX3 as a reliable biomarker for the diagnosis and prognosis of primary liver cancer and to explore the specific mechanisms responsible for the increased serum PTX3 levels in liver cancer patients. Here, PTX3 is linked to liver cancer.